Study D3250C00059: A Phase 4, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Evaluate the Effect of Benralizumab on Structural and Lung Function Changes in Severe Eosinophilic Asthmatics (CHINOOK)

Project: Research project

Project Details

StatusActive
Effective start/end date8/19/19 → 8/18/28

Funding

  • AstraZeneca LP: $11,405.00